‘Robbing Peter to pay Paul’: Obesity experts debate risks of new weight loss drugs
Amid rising demand for drugs like Wegovy, Ozempic, and Mounjaro that can lead to significant…
Category: breakthrough2023
STAT+: 4 ways the health care system should shift its thinking on AI, according to experts
This week, the “Godfather of AI” Geoffrey Hinton made news when he left Google and…
STAT+: Doudna talks cost, access issues looming over first CRISPR therapy
Jennifer Doudna may be just months away from seeing the first CRISPR-based therapy gain approval,…
STAT+: Gilead foresees more growth in its HIV drugs
Gilead Sciences is famous — or perhaps, notorious — for its cure for hepatitis C….
‘Are we better off with the information?’: Experts spar over the benefits of liquid biopsy to catch cancer
New technologies are making it possible to detect cancer earlier than ever — but the…
STAT+: A new list ranks large pharmaceutical companies by research and development
If you want a large pharmaceutical company to invent a new drug, your best bet…
12,000 diseases lack treatments. One doctor thinks generics could yield cures
SAN FRANCISCO — About a decade ago, David Fajgenbaum thought his life was over. He…
An MRI helmet out of ‘Back to the Future’ wins STAT Summit research pick
The pitches are as ambitious as they are exciting: a gel to rub onto your…
Don’t ignore potential microbial causes of Alzheimer’s and other chronic diseases, researchers say
SAN FRANCISCO — On a day when pharma giant Eli Lilly announced positive results from…
STAT+: Vinod Khosla predicts AI doctors could be here sooner than you think
Sun Microsystems co-founder Vinod Khosla is famous for predictions that have helped usher in the…
For Eli Lilly’s head scientist, Alzheimer’s results cap a 25-year scientific quest
If you flip to the 1,031st page of the May 1998 edition of the Journal…